For the quarter ending 2025-09-30, ALKS had $95,250K increase in cash & cash equivalents over the period. $84,358K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income | 82,761 | 109,562 |
| Depreciation and amortization | 8,080 | 15,239 |
| Share-based compensation expense | 24,665 | 47,776 |
| Deferred income taxes | 31,394 | -900 |
| Other non-cash charges | 1,151 | 3,245 |
| Receivables | -512 | -29,622 |
| Contract assets | -707 | -3,566 |
| Inventory | -845 | 10,043 |
| Prepaid expenses and other assets | 19,147 | -16,163 |
| Right-of-use assets | -1,915 | -3,713 |
| Accounts payable and accrued expenses | -28,245 | 56,109 |
| Accrued sales discounts, allowances and reserves | -430 | -19,279 |
| Contract liabilities | -578 | -671 |
| Operating lease liabilities | -2,596 | -5,137 |
| Other long-term liabilities | 638 | 48 |
| Cash flows provided by operating activities | 101,672 | 249,013 |
| Additions of property, plant and equipment | 17,314 | 23,126 |
| Proceeds from the sale of property, plant and equipment | 0 | 34 |
| Proceeds from the sale of the athlone facility | 0 | 1,708 |
| Purchases of investments | 114,728 | 193,806 |
| Sales and maturities of investments | 125,305 | 195,078 |
| Cash flows (used in) investing activities | -6,737 | -20,112 |
| Proceeds from the issuance of ordinary shares under share-based compensation arrangements | 622 | 31,611 |
| Employee taxes paid related to net share settlement of equity awards | 307 | 30,459 |
| Cash flows provided by (used in) financing activities | 315 | 1,152 |
| Net increase (decrease) in cash and cash equivalents | 95,250 | 230,053 |
| Cash and cash equivalents at beginning of period | 291,146 | - |
| Cash and cash equivalents at end of period | 616,449 | - |
Alkermes plc. (ALKS)
Alkermes plc. (ALKS)